Financial insights of CDNA

MyFinsight

For the quarter ending 2025-09-30, CDNA made $100,055K in revenue. $1,675K in net income. Net profit margin of 1.67%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Total revenue	100,055	86,679	84,685	82,883
Cost of testing services, product, patient and digital solutions-Service	14,705	15,406	-	-
Cost of testing services, product, patient and digital solutions-Product	5,629	4,981	-	-
Cost of testing services, product, patient and digital solutions-Patient And Digital Solutions	10,320	8,271	-	-
Research and development	16,769	16,830	18,524	17,486
Sales and marketing	24,449	24,279	22,991	19,802
General and administrative	28,429	27,683	22,769	28,515
Litigation settlement expense	0	-350	-5,360	-
Cost of testing services, product, digital, and other	-	-	28,415	27,572
Total operating expenses	100,301	97,800	98,059	93,375
Loss from operations	-246	-11,121	-13,374	-10,492
Interest income, net	2,013	2,364	2,784	3,001
Other (expense) income, net	-107	72	295	283
Total other income	1,906	2,436	3,079	3,284
Income (loss) before income taxes	1,660	-8,685	-10,295	-7,208
Income tax benefit (expense)	-15	-117	58	200
Net income (loss)	1,675	-8,568	-10,353	-7,408

Basic (in shares)	52,507,582	54,304,754	55,262,459	52,903,338
Basic (in usd per share)	0.03	-0.16	-0.19	-0.14
Diluted (in shares)	53,736,790	54,304,754	55,262,459	52,903,338
Diluted (in usd per share)	0.03	-0.16	-0.19	-0.14